OLIVER LAGORE VANVALIN INVESTMENT GROUP - WEREWOLF THERAPEUTICS INC ownership

WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 39 filers reported holding WEREWOLF THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
OLIVER LAGORE VANVALIN INVESTMENT GROUP ownership history of WEREWOLF THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$3,000
+50.0%
5800.0%0.00%
+100.0%
Q2 2022$2,000
-33.3%
5800.0%0.00%
-50.0%
Q1 2022$3,0005800.00%
Other shareholders
WEREWOLF THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
DC Funds, LP 589,102$1,207,65932.70%
MPM ASSET MANAGEMENT LLC 4,284,172$8,782,5533.68%
MPM BioImpact LLC 2,388,011$4,895,4231.27%
SPHERA FUNDS MANAGEMENT LTD. 626,810$1,284,9610.28%
RA Capital Management 4,291,881$8,798,3560.18%
Rubric Capital Management LP 1,835,387$3,762,5430.16%
Tejara Capital Ltd 128,800$264,0400.15%
Oasis Management Co Ltd. 246,305$504,9250.10%
PFM Health Sciences, LP 1,293,293$2,651,2510.10%
Laurion Capital Management LP 522,900$1,071,9450.01%
View complete list of WEREWOLF THERAPEUTICS INC shareholders